138 related articles for article (PubMed ID: 30548138)
21. Utilization of direct smears of thyroid fine-needle aspirates for ancillary molecular testing: A comparison of two proprietary testing platforms.
Partyka KL; Randolph ML; Lawrence KA; Cramer H; Wu HH
Diagn Cytopathol; 2018 Apr; 46(4):320-325. PubMed ID: 29446257
[TBL] [Abstract][Full Text] [Related]
22. Comparative analysis of diagnostic performance, feasibility and cost of different test-methods for thyroid nodules with indeterminate cytology.
Sciacchitano S; Lavra L; Ulivieri A; Magi F; De Francesco GP; Bellotti C; Salehi LB; Trovato M; Drago C; Bartolazzi A
Oncotarget; 2017 Jul; 8(30):49421-49442. PubMed ID: 28472764
[TBL] [Abstract][Full Text] [Related]
23. A Comparative Analysis of Liquid-Based Cytology and Conventional Smears in Fine-Needle Aspirates of Thyroid Lesions.
Maurya MK; Yadav R; Kumar M; Singh HP; Mishra A; Goel MM
Cureus; 2023 Sep; 15(9):e45353. PubMed ID: 37849573
[TBL] [Abstract][Full Text] [Related]
24. Risk stratification of the thyroid nodule with Bethesda indeterminate cytology, category III, IV, V on the one surgeon-performed US-guided fine-needle aspiration with 27-gauge needle, verified by histopathology of thyroidectomy: the additional value of one surgeon-performed elastography.
Sengul D; Sengul I; Van Slycke S
Acta Chir Belg; 2019 Feb; 119(1):38-46. PubMed ID: 30606092
[TBL] [Abstract][Full Text] [Related]
25. Molecular analysis of residual ThinPrep material from thyroid FNAs increases diagnostic sensitivity.
Krane JF; Cibas ES; Alexander EK; Paschke R; Eszlinger M
Cancer Cytopathol; 2015 Jun; 123(6):356-61. PubMed ID: 25926393
[TBL] [Abstract][Full Text] [Related]
26. Impact of proto-oncogene mutation detection in cytological specimens from thyroid nodules improves the diagnostic accuracy of cytology.
Cantara S; Capezzone M; Marchisotta S; Capuano S; Busonero G; Toti P; Di Santo A; Caruso G; Carli AF; Brilli L; Montanaro A; Pacini F
J Clin Endocrinol Metab; 2010 Mar; 95(3):1365-9. PubMed ID: 20130073
[TBL] [Abstract][Full Text] [Related]
27. Targeted Next Generation Sequencing with ThyroSeq v2.1 for Indeterminate Thyroid Nodules in Clinical Practice.
Witt RL
Del Med J; 2016 Dec; 88(12):366-372. PubMed ID: 29461717
[TBL] [Abstract][Full Text] [Related]
28. Analytical performance of the ThyroSeq v3 genomic classifier for cancer diagnosis in thyroid nodules.
Nikiforova MN; Mercurio S; Wald AI; Barbi de Moura M; Callenberg K; Santana-Santos L; Gooding WE; Yip L; Ferris RL; Nikiforov YE
Cancer; 2018 Apr; 124(8):1682-1690. PubMed ID: 29345728
[TBL] [Abstract][Full Text] [Related]
29. Correlation Between Histological Diagnosis and Mutational Panel Testing of Thyroid Nodules: A Two-Year Institutional Experience.
Shrestha RT; Evasovich MR; Amin K; Radulescu A; Sanghvi TS; Nelson AC; Shahi M; Burmeister LA
Thyroid; 2016 Aug; 26(8):1068-76. PubMed ID: 27283257
[TBL] [Abstract][Full Text] [Related]
30. The combination of four molecular markers improves thyroid cancer cytologic diagnosis and patient management.
Panebianco F; Mazzanti C; Tomei S; Aretini P; Franceschi S; Lessi F; Di Coscio G; Bevilacqua G; Marchetti I
BMC Cancer; 2015 Nov; 15():918. PubMed ID: 26581891
[TBL] [Abstract][Full Text] [Related]
31. Indeterminate Single Thyroid Nodule: Synergistic Impact of Mutational Markers and Sonographic Features in Triaging Patients to Appropriate Surgery.
De Napoli L; Bakkar S; Ambrosini CE; Materazzi G; Proietti A; Macerola E; Basolo F; Miccoli P
Thyroid; 2016 Mar; 26(3):390-4. PubMed ID: 26548748
[TBL] [Abstract][Full Text] [Related]
32. ACR TI-RADS and ATA US scores are helpful for the management of thyroid nodules with indeterminate cytology.
Barbosa TLM; Junior COM; Graf H; Cavalvanti T; Trippia MA; da Silveira Ugino RT; de Oliveira GL; Granella VH; de Carvalho GA
BMC Endocr Disord; 2019 Oct; 19(1):112. PubMed ID: 31664992
[TBL] [Abstract][Full Text] [Related]
33. Combined quantitation of HMGA2 mRNA, microRNAs, and mitochondrial-DNA content enables the identification and typing of thyroid tumors in fine-needle aspiration smears.
Titov SE; Ivanov MK; Demenkov PS; Katanyan GA; Kozorezova ES; Malek AV; Veryaskina YA; Zhimulev IF
BMC Cancer; 2019 Oct; 19(1):1010. PubMed ID: 31660895
[TBL] [Abstract][Full Text] [Related]
34. Pilot of BRAF mutation analysis in indeterminate, suspicious and malignant thyroid FNA cytology.
Johnson SJ; Hardy SA; Roberts C; Bourn D; Mallick U; Perros P
Cytopathology; 2014 Jun; 25(3):146-54. PubMed ID: 24417615
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic usefulness of tumor markers in the thyroid cytological samples extracted by fine-needle aspiration biopsy.
Gómez Sáez JM
Endocr Metab Immune Disord Drug Targets; 2010 Mar; 10(1):47-56. PubMed ID: 20088814
[TBL] [Abstract][Full Text] [Related]
36. Molecular Classification of Thyroid Nodules with Indeterminate Cytology: Development and Validation of a Highly Sensitive and Specific New miRNA-Based Classifier Test Using Fine-Needle Aspiration Smear Slides.
Santos MTD; Buzolin AL; Gama RR; Silva ECAD; Dufloth RM; Figueiredo DLA; Carvalho AL
Thyroid; 2018 Dec; 28(12):1618-1626. PubMed ID: 30319072
[No Abstract] [Full Text] [Related]
37. Molecular-Directed Treatment of Differentiated Thyroid Cancer: Advances in Diagnosis and Treatment.
Yip L; Sosa JA
JAMA Surg; 2016 Jul; 151(7):663-70. PubMed ID: 27223483
[TBL] [Abstract][Full Text] [Related]
38. Development and Analytical Validation of an Expanded Mutation Detection Panel for Next-Generation Sequencing of Thyroid Nodule Aspirates.
Ablordeppey KK; Timmaraju VA; Song-Yang JW; Yaqoob S; Narick C; Mireskandari A; Finkelstein SD; Kumar G
J Mol Diagn; 2020 Mar; 22(3):355-367. PubMed ID: 31866571
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of a Two-Year Routine Application of Molecular Testing of Thyroid Fine-Needle Aspirations Using a Seven-Gene Panel in a Primary Referral Setting in Germany.
Eszlinger M; Böhme K; Ullmann M; Görke F; Siebolts U; Neumann A; Franzius C; Adam S; Molwitz T; Landvogt C; Amro B; Hach A; Feldmann B; Graf D; Wefer A; Niemann R; Bullmann C; Klaushenke G; Santen R; Tönshoff G; Ivancevic V; Kögler A; Bell E; Lorenz B; Kluge G; Hartenstein C; Ruschenburg I; Paschke R
Thyroid; 2017 Mar; 27(3):402-411. PubMed ID: 28071986
[TBL] [Abstract][Full Text] [Related]
40. Analytic and clinical validity of thyroid nodule mutational profiling using droplet digital polymerase chain reaction.
Biron VL; Matkin A; Kostiuk M; Williams J; Cote DW; Harris J; Seikaly H; O'Connell DA
J Otolaryngol Head Neck Surg; 2018 Sep; 47(1):60. PubMed ID: 30249281
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
